Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development
- PMID: 16418395
- PMCID: PMC2118073
- DOI: 10.1084/jem.20051645
Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development
Abstract
Flt3 ligand (Flt3L) is a nonredundant cytokine in type I interferon-producing cell (IPC) and dendritic cell (DC) development, and IPC and DC differentiation potential is confined to Flt3+ hematopoietic progenitor cells. Here, we show that overexpression of human Flt3 in Flt3- (Flt3(-)Lin(-)IL-7Ralpha(-)Thy1.1(-)c-Kit+) and Flt3+ (Flt3(+)Lin(-)IL-7Ralpha(-)Thy1.1(-)c-Kit+) hematopoietic progenitors rescues and enhances their IPC and DC differentiation potential, respectively. In defined hematopoietic cell populations, such as Flt3- megakaryocyte/erythrocyte-restricted progenitors (MEPs), enforced Flt3 signaling induces transcription of IPC, DC, and granulocyte/macrophage (GM) development-affiliated genes, including STAT3, PU.1, and G-/M-/GM-CSFR, and activates differentiation capacities to these lineages. Moreover, ectopic expression of Flt3 downstream transcription factors STAT3 or PU.1 in Flt3- MEPs evokes Flt3 receptor expression and instructs differentiation into IPCs, DCs, and myelomonocytic cells, whereas GATA-1 expression and consecutive megakaryocyte/erythrocyte development is suppressed. Based on these data, we propose a demand-regulated, cytokine-driven DC and IPC regeneration model, in which high Flt3L levels initiate a self-sustaining, Flt3-STAT3- and Flt3-PU.1-mediated IPC and DC differentiation program in Flt3+ hematopoietic progenitor cells.
Figures
Similar articles
-
Flt3 in regulation of type I interferon-producing cell and dendritic cell development.Ann N Y Acad Sci. 2007 Jun;1106:253-61. doi: 10.1196/annals.1392.015. Epub 2007 Mar 14. Ann N Y Acad Sci. 2007. PMID: 17360795 Review.
-
Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow.Nat Immunol. 2007 Nov;8(11):1207-16. doi: 10.1038/ni1518. Epub 2007 Oct 7. Nat Immunol. 2007. PMID: 17922016
-
Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.J Immunol. 1999 Sep 1;163(5):2648-56. J Immunol. 1999. PMID: 10453005
-
Dendritic cell lineage commitment is instructed by distinct cytokine signals.Eur J Cell Biol. 2012 Jun-Jul;91(6-7):515-23. doi: 10.1016/j.ejcb.2011.09.007. Epub 2011 Nov 9. Eur J Cell Biol. 2012. PMID: 22078373
-
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
Cited by
-
Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice.Clin Exp Immunol. 2012 Nov;170(2):156-66. doi: 10.1111/j.1365-2249.2012.04641.x. Clin Exp Immunol. 2012. PMID: 23039886 Free PMC article.
-
Regulation of plasmacytoid dendritic cell development.Curr Opin Immunol. 2010 Apr;22(2):206-11. doi: 10.1016/j.coi.2010.01.005. Epub 2010 Feb 9. Curr Opin Immunol. 2010. PMID: 20144853 Free PMC article. Review.
-
Transcription factor networks in dendritic cell development.Semin Immunol. 2011 Oct;23(5):388-97. doi: 10.1016/j.smim.2011.08.009. Epub 2011 Sep 15. Semin Immunol. 2011. PMID: 21924924 Free PMC article. Review.
-
STAT3 signaling in immunity.Cytokine Growth Factor Rev. 2016 Oct;31:1-15. doi: 10.1016/j.cytogfr.2016.05.001. Epub 2016 May 9. Cytokine Growth Factor Rev. 2016. PMID: 27185365 Free PMC article. Review.
-
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics.J Immunol Res. 2019 Jun 11;2019:7458238. doi: 10.1155/2019/7458238. eCollection 2019. J Immunol Res. 2019. PMID: 31309123 Free PMC article.
References
-
- Kondo, M., A.J. Wagers, M.G. Manz, S.S. Prohaska, D.C. Scherer, G.F. Beilhack, J.A. Shizuru, and I.L. Weissman. 2003. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21:759–806. - PubMed
-
- Akashi, K., D. Traver, T. Miyamoto, and I.L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:193–197. - PubMed
-
- Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 3:459–473. - PubMed
-
- Kondo, M., I.L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:661–672. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous